CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($) $ in Thousands	Preferred Stock [Member]	Common Stock [Member]	Additional Paid-in Capital [Member]	Accumulated Deficit [Member]	Total Precipio, Inc. [Member]	Noncontrolling Interest in Joint Venture [Member]	Total
Balance at beginning of period at Dec. 31, 2020		$ 176	$ 85,523	$ (71,564)	$ 14,135	$ 27	$ 14,162
Balance at beginning of period (in shares) at Dec. 31, 2020	47	17,576,916
Increase (Decrease) in Stockholders' Equity
Net loss				(4,465)	(4,465)	4	(4,461)
Issuance of common stock in connection with purchase agreements		$ 5	1,255		1,260		1,260
Issuance of common stock in connection with purchase agreements (in shares)		500,000
Issuance of common stock in connection with at the market offering, net of issuance costs		$ 45	14,902		14,947		14,947
Issuance of common stock in connection with at the market offering, net of issuance costs (in shares)		4,501,000
Proceeds upon issuance of common stock from exercise of warrants		$ 1	399		400		400
Proceeds upon issuance of common stock from exercise of warrants (in shares)		74,000
Issuance of common stock for consulting services		$ 200	150		150		150
Issuance of common stock for consulting services (in shares)		55,147
Stock-based compensation			800		800		800
Balance at end of period at Jun. 30, 2021		$ 227	103,029	(76,029)	27,227	31	27,258
Balance at end of period (in shares) at Jun. 30, 2021	47	22,707,063
Balance at beginning of period at Mar. 31, 2021		$ 181	87,365	(73,016)	14,530	28	14,558
Balance at beginning of period (in shares) at Mar. 31, 2021	47	18,132,063
Increase (Decrease) in Stockholders' Equity
Net loss				(3,013)	(3,013)	3	(3,010)
Issuance of common stock in connection with at the market offering, net of issuance costs		$ 45	14,902		14,947		14,947
Issuance of common stock in connection with at the market offering, net of issuance costs (in shares)		4,501,000
Proceeds upon issuance of common stock from exercise of warrants		$ 1	399		400		400
Proceeds upon issuance of common stock from exercise of warrants (in shares)		74,000
Stock-based compensation			363		363		363
Balance at end of period at Jun. 30, 2021		$ 227	103,029	(76,029)	27,227	31	27,258
Balance at end of period (in shares) at Jun. 30, 2021	47	22,707,063
Balance at beginning of period at Dec. 31, 2021		$ 227	104,431	(80,094)	24,564	40	24,604
Balance at beginning of period (in shares) at Dec. 31, 2021	47	22,708,442
Increase (Decrease) in Stockholders' Equity
Net loss				(6,734)	(6,734)	12	(6,722)
Proceeds upon issuance of common stock from exercise of warrants (in shares)		266
Stock-based compensation			2,683		2,683		2,683
Balance at end of period at Jun. 30, 2022		$ 227	107,114	(86,828)	20,513	52	20,565
Balance at end of period (in shares) at Jun. 30, 2022	47	22,708,708
Balance at beginning of period at Mar. 31, 2022		$ 227	106,663	(84,684)	22,206	46	22,252
Balance at beginning of period (in shares) at Mar. 31, 2022	47	22,708,708
Increase (Decrease) in Stockholders' Equity
Net loss				(2,144)	(2,144)	6	(2,138)
Stock-based compensation			451		451		451
Balance at end of period at Jun. 30, 2022		$ 227	$ 107,114	$ (86,828)	$ 20,513	$ 52	$ 20,565
Balance at end of period (in shares) at Jun. 30, 2022	47	22,708,708